Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Graham

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 16, 2006
A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal-cord compression treated by radiotherapy: TROG 01.05 Superdex studyP H Graham, A Capp, G Delaney, et al.
Cell Death & Disease|October 26, 2013
Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistanceL Chang, P H Graham, J Hao, et al.
Cell Death & Disease|October 3, 2014
PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathwaysL Chang, P H Graham, J Hao, et al.
Australasian Radiology|August 4, 2006
Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapyP H Graham, C Clark, F Abell, et al.
Journal of Medical Imaging and Radiation Oncology|June 17, 2009
Radioresistant malignant myoepithelioma of the breast with high level of ataxia telangiectasia mutated proteinZ M Fang, R V Tse, V M Marjoniemi, et al.
British Journal of Cancer|June 30, 2011
Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53E K A Millar, P H Graham, C M McNeil, et al.
The British Journal of Surgery|January 7, 2020
International multicentre review of perioperative management and outcome for catecholamine-producing tumoursH Groeben, M K Walz, B J Nottebaum, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 16, 2006
A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal-cord compression treated by radiotherapy: TROG 01.05 Superdex studyP H Graham, A Capp, G Delaney, et al.
Cell Death & Disease|October 26, 2013
Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistanceL Chang, P H Graham, J Hao, et al.
Cell Death & Disease|October 3, 2014
PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathwaysL Chang, P H Graham, J Hao, et al.
Australasian Radiology|August 4, 2006
Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapyP H Graham, C Clark, F Abell, et al.
Journal of Medical Imaging and Radiation Oncology|June 17, 2009
Radioresistant malignant myoepithelioma of the breast with high level of ataxia telangiectasia mutated proteinZ M Fang, R V Tse, V M Marjoniemi, et al.
British Journal of Cancer|June 30, 2011
Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53E K A Millar, P H Graham, C M McNeil, et al.
The British Journal of Surgery|January 7, 2020
International multicentre review of perioperative management and outcome for catecholamine-producing tumoursH Groeben, M K Walz, B J Nottebaum, et al.
Pageof 4